DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Steeneck C. * Kinzel O, Anderhub S, Hornberger M, Pinto S, Morschhaeuser B, Braun F, Kleymann G, Hoffmann T. Phenex Pharmaceuticals AG, Heidelberg, Germany
Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation.
ACS Med. Chem. Lett. 2020;
11: 179-187
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.